BHealthCare
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BHealthCare - overview
Established
2016
Location
Saint-Herblain, Pays de la Loire, France
Primary Industry
Medical Devices & Equipment
About
BHealthCare is a medical technology firm specializing in innovative robotic solutions to enhance blood collection processes in healthcare settings, focusing on improving patient comfort and operational efficiency. Founded in 2016 in Saint-Herblain, France, BHealthCare develops advanced medical solutions aimed at optimizing blood collection. The company has completed a total of 6 deals, with the most recent funding round occurring on June 21, 2024, amounting to EUR 2. 50 mn, which matches the total amount raised to date, EUR 2.
50 mn. The company is led by CEO Aliaume Breteau, who co-founded BHealthCare alongside Jean-Baptiste de Chaisemartin. BHealthCare specializes in the development of HEIVA, an innovative medical robotic solution designed to enhance the blood collection process for patients. This device utilizes advanced imaging technology and precision robotics to ensure an accurate first stick attempt, significantly improving patient comfort and safety during blood draws.
The primary end users of HEIVA include healthcare facilities such as hospitals and laboratories, aiming to address common challenges in blood collection, including high preanalytical error rates. BHealthCare generates revenue through direct sales of the HEIVA device to healthcare institutions and laboratories, focusing on partnerships and collaborations within the medical sector. The transaction structure primarily involves B2B interactions, where hospitals and clinics acquire the robotic solution to enhance their blood collection processes. While specific pricing details for the HEIVA system are not disclosed, the financial model encompasses initial purchase agreements followed by potential service contracts for maintenance and support.
In June 2024, BHealthCare raised EUR 2. 50 mn from unspecified investors, which will be utilized to support the further development of their HEIVA solution and expand their market presence. The company aims to launch new features for HEIVA targeting healthcare markets not only within France but also across Europe by the end of 2025, addressing the growing demand for efficient blood testing solutions.
Primary Industry
Medical Devices & Equipment
Sub Industries
Monitoring Equipment, Diagnostic Equipment
Website
www.bhealthcare.fr
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
BHealthCare - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.